102
Chemistry Letters Vol.37, No.1 (2008)
Chemical Aminoacylation of RNA by an Intermolecular Adenosine Transfer Reaction
Mingzhe Liu, Hiroshi Jinmei, Hiroshi Abe,ꢀ and Yoshihiro Itoꢀ
Nano Medical Engineering Laboratory, RIKEN (The Institute of Physical and Chemical Research),
2-1 Hirosawa, Wako 351-0198
(Received September 10, 2007; CL-070986; E-mail: h-abe@riken.jp, y-ito@riken.jp)
RNA aminoacylation, based on an adenosine transfer mech-
amino acids. The transfer chemistry is a nucleophilic substitu-
tion reaction, which has formerly been used for the chemical li-
gation of nucleic acids.9–12 In the present study, we designed the
model system shown in Scheme 1, to confirm the transfer of ami-
noacylated adenosine 2 from the donor probe to the acceptor
RNA in the chemical reaction. When tRNA lacking a 30-terminal
adenosine is used as the acceptor, the aminoacylation of the
tRNA can be achieved.
anism, was achieved by the intermolecular transfer of phenylala-
ninyl adenosine from a donor probe to an acceptor RNA. This
method can be applied to a wide variety of unnatural amino acids
for tRNA aminoacylation.
tRNA aminoacylated with unnatural amino acids has be-
come a powerful tool for the site-specific incorporation of un-
natural amino acids into proteins. This has been used for various
applications, such as the investigation of protein–protein interac-
tions, conformational changes, and signal transduction.1–8 The
synthesis of aminoacylated tRNA has been reported by several
research groups. These approaches can be divided into two main
classes: enzymatic and nonenzymatic methods. Among the en-
zymatic methods, Hecht’s group first reported a general strategy
for the preparation of aminoacylated tRNA, in which T4 RNA
ligase attaches an aminoacylated pCpA derivative to tRNAs
lacking a 30-terminal dinucleotide.4 Suga’s group reported
RNA ribozymes that catalyze the aminoacylation of tRNAs with
phenylalanine derivatives as substrates.5 Mutated aminoacyl
tRNA synthetase catalyzing the aminoacylation of phenylala-
nine derivatives has been developed independently by Schultz’s
group and Yokoyama’s group.6,7 Although each of these tech-
niques has some advantages, they also have some restrictions
in their ability to selectively aminoacylate tRNA, or in their ap-
plicability to a wide range of substrate amino acids and tRNA.
Recently, Sisido’s group developed a novel nonenzymatic meth-
od for the aminoacylation of tRNA, which can be applied to a
wide variety of unnatural amino acids. The method is based on
an aminoacyl transfer mechanism using a peptide nucleic acid
(PNA) probe.8
The structures of the donor probe and the acceptor RNA
used are shown in Scheme 1. The donor consists of three parts:
an oligonucleotide (DNA), a linker, and an adenosine derivative
(R = 1 or 2). The donor probe binds to the acceptor to form a
DNA–RNA double strand before the transfer reaction. The ade-
nosine derivative is linked to the deoxyoligonucleotide by an
electrophilic linker containing a benzenesulfonyl group, which
makes the 50-hydroxy group of the adenosine (1 or 2) reactive
to nucleophilic substitution. The acceptor consists of an RNA
strand, except for deoxycytidine at the 30-terminus, which
has a phosphorothioate group. When the donor and acceptor
are hybridized, the phosphorothioate group of the acceptor
attacks the 50-carbon center of the adenosine in the donor probe.
The transfer of the adenosine derivative then proceeds from the
donor probe to the acceptor RNA.
First, the donor probe was synthesized according to
Scheme 2. Key compounds 3 and 4 were designed to contain
two electrophilic reactive centers, a bromoacetyl group and a
benzenesulfonyl group. The reactivity of the bromoacetyl group
in nucleophilic substitution is significantly higher than that of the
benzenesulfonyl group. Therefore, when the phosphorothioate
probe is mixed with compound 3 or 4, the bromoacetyl group se-
lectively reacts with the thioxide anion of the phosphorothioate
group, generating the donor probe (Scheme 2). The synthesis of
the protected adenosine derivative 3 and the phenylalanyl adeno-
sine derivative 4 is described in the Supporting Information.
Both compounds were synthesized from commercially available
Here, we propose a new nonenzymatic strategy for tRNA-
specific aminoacylation, which is based on an adenosine transfer
mechanism. This can be applied to a wide range of unnatural
O
R
O
S
donor 1: R = 1
donor 2: R = 2
dGdGdTdCdCdGdGdCdGdG-3'
O
O
dC rC rA rG rG rCrC rG rC rC rCrGrGrCrC-32P-5'
-S P O
O-
acceptor
NH2
N
HN Boc
N
N
N
N
N
N
N
O
Transfer of
O
O
dGdGdTdCdCdGdGdCdGdG-3'
adenosine derivative
HO
S
R-
=
O
O
O
O
O
O
dCrCrArGrGrCrCrGrCrCrCrGrGrCrC-32P-5'
product 1: R = 1
product 2: R = 2
O
S P O
R
O-
H2N
1
2
Scheme 1. Principle of intermolecular transfer of adenosine derivative from donor to acceptor.
Copyright ꢀ 2008 The Chemical Society of Japan